Subscribe To
Axos financial: highly profitable and returning potential 19%
Axos Financial's stock has fallen nearly 40% from all-time highs, but the bank is still growing revenues and EPS. The stock is deeply discounted, and ...
September 27, 2023, 2:18 am
Federal realty investment trust: buying for the recovery play
Federal Realty Investment Trust is a quality dividend king in the REIT industry, offering a secure 4.7% yield. FRT has a ...
September 26, 2023, 12:25 pm
Atlantica sustainable: combine its 8.6% yield with covered calls for a ~15% annualized income yield
Shares of Atlantica Sustainable Infrastructure have declined by 31.5% over the past year, resulting in a near-all-time high dividend yield of 8.6%. Ho...
September 26, 2023, 11:30 am
Ignore uaw, stellantis is still a solid bet
Stellantis, arising from the merger of Fiat-Chrysler and PSA, stands as a formidable presence in the automotive industry with a ...
September 26, 2023, 2:25 am
Will grocery outlet's (go) plan of growing store presence aid?
Grocery Outlet (GO) is positioned to flourish and effectively cater to its diverse customer base on a d...
September 25, 2023, 1:32 pm
Ryvyl to present at ld micro main event xvi
SAN DIEGO, CA, Sept. 25, 2023 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”), a leading innovator of payment transa...
September 25, 2023, 12:00 pm
Core molding technologies: margins are expanding quickly
Core Molding Technologies has seen a significant increase in its share price and has access to a large total addressable market valued at over $10 bil...
September 25, 2023, 4:37 am
Shift4 payments: a strong buy in the payments processing industry
The company specializes in delivering payment services to a diverse clientele and has made strategic ac...
September 25, 2023, 1:42 am
Coke: double-digit upside in 2023, looking forward.
Coca-Cola Consolidated (COKE) is the largest bottler in the US with a 120-year history and a significant upside potential. The company has seen increa...
September 24, 2023, 5:42 am
Dick's is impressive - but is it enough?
DICK'S Sporting Goods excels with strong sales, rising dividends, and a robust market strategy. The company's success lies in in-store expertise, a ...
September 24, 2023, 4:39 am
Aldeyra:upcoming pdufa, strong nda, long pipeline, decent cash
Aldeyra is a late-stage company developing therapies for immune-mediated diseases, with a focus on dry eye disease and allergic conjunctivitis. Their ...
September 22, 2023, 7:44 pm
Hershey: lack of growth does not seem very attractive
Hershey Company is the second largest chocolate manufacturing company in the US, but its future growth prospects are uncertain. The company has a stro...
September 22, 2023, 3:32 pm
Marex diversifies portfolio with cowen prime brokerage acquisition
Marex will acquire Cowen's prime brokerage and outsourced trading business. This move is part of its strategy to enhance its capabilities, broaden its...
September 22, 2023, 1:57 pm
Markets.com’s stavros anastasiou on what makes a successful business
Can you tell me what makes Markets.com unique relative to other competitors in the industry?Markets.com has a fantastically inclusive trading ecosyste...
September 22, 2023, 6:06 am
Mattel (mat) gains 32% in 6 months: will the rally continue?
Mattel (MAT) benefits from its diverse product portfolio, Optimizing for Growth program and focus on IP...
September 21, 2023, 12:02 pm
Top 10 llc business bank account options
Discover the top 9 online business bank accounts. Explore diverse options for your business banking req...
September 21, 2023, 8:29 am
Udr: buy the drop on this unloved dividend stock
UDR stock is now trading slightly above its 52-week low, presenting a potential opportunity for value investors. It's a multifamily REIT with a ...
September 21, 2023, 8:10 am
Cgdv: actively managed dividend etf beating the market
CGDV is an actively managed dividend ETF that outperformed SPY in 2022 and has kept pace in 2023, an impressive feat given how growth stocks have domi...
September 21, 2023, 4:41 am
Predicine announces new study published in the new england journal of medicine demonstrating clinical utility of its mrd liquid biopsy assay in supporting genentech’s phase 1 clinical trial of divaras
PredicineBEACON™ and PredicineWES+™ were used to detect and monitor a diverse spectrum of genomic a...
September 20, 2023, 5:12 pm
Predicine announces new study published in the new england journal of medicine demonstrating clinical utility of its mrd liquid biopsy assay in supporting genentech’s phase 1 clinical trial of divaras
PredicineBEACON™ and PredicineWES+™ were used to detect and monitor a diverse spectrum of genomic a...
September 20, 2023, 5:12 pm